Tag: FDA

FDA: Hospira recalls 8.4% Sodium Bicarbonate Injection

Editor's Note The Food and Drug Administration (FDA) on March 15 announced the recall by Hospira, Inc (a Pfizer company) of three lots of its 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL). The recall was initiated because of the presence of particulate matter, confirmed as glass. The…

Read More

By: Judy Mathias
March 18, 2019
Share

FDA: Guardian Pharmacy ordered to stop producing sterile compounded drugs

Editor's Note The Food & Drug Administration on March 12 announced that a federal judge entered a consent decree against Guardian Pharmacy Services (Dallas, Texas) to stop the company from producing compounded drug products intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic (FD&C)…

Read More

By: Judy Mathias
March 14, 2019
Share

FDA issues letter on risks linked with staplers, implantable staples

Editor's Note The Food and Drug Administration (FDA) on March 8 issued a letter to alert healthcare providers about an increasing number of medical device reports on surgical staplers for internal use and implantable surgical staples. The most common reported problems include opening of the staple line, malformation of staples,…

Read More

By: Judy Mathias
March 11, 2019
Share

FDA: Class I recall of RVO 2.0 Raindrop near vision inlay

Editor's Note The Food & Drug Administration (FDA) on March 5 identified the recall by RVO 2.0, Inc (Aliso Viejo, California) of its Raindrop near vision inlay as Class I, the most serious. All lots of the inlay are being recalled because data from the post-approval study showed an increased…

Read More

By: Judy Mathias
March 6, 2019
Share

FDA issues Safety Communication on using surgical robots in women’s health

Editor's Note The Food and Drug Administration (FDA) on February 28 issued a Safety Communication on the safety and effectiveness of using robotically-assisted surgical devices in mastectomy procedures or in the prevention or treatment of cancer in women. The FDA cited limited, preliminary evidence that the use of robotically-assisted surgical…

Read More

By: Judy Mathias
March 5, 2019
Share

FDA: Class I recall of Physio-Control LIFEPAK 15 Monitor/Defibrillator

Editor's Note The Food & Drug Administration (FDA) on February 27 identified the recall by Physio-Control, Inc (Redmond, Washington) of its LIFEPAK 15 Monitor/Defibrillator as Class I, the most serious. The recall was initiated because the device may “lockup” (freeze) after a shock is delivered. Once it freezes, it cannot…

Read More

By: Judy Mathias
February 28, 2019
Share

FDA: Class I recall of ICU Medical’s ChemoLock Vial Spike

Editor's Note The Food & Drug Administration (FDA) on February 22 identified the recall by ICU Medical (San Clemente, California) of its ChemoLock Vial Spike (20 mm) as Class I, the most serious. The recall was initiated because of the potential for plastic particles to break off the protective cap.…

Read More

By: Judy Mathias
February 25, 2019
Share

FDA: Class I recall of Smiths Medical Sterile Saline and Water for Inhalation

Editor's Note The Food & Drug Administration (FDA) on February 4 identified the recall by Smiths Medical (Minneapolis, Minnesota) of certain lots of Sterile Saline and Water for Inhalation as Class I, the most serious. The recall was initiated because of potential exposure to infectious agents (bacillus infantis and staphylococcus…

Read More

By: Judy Mathias
February 21, 2019
Share

FDA: Class I recall of Medtronic’s Dual Chamber Implantable Pulse Generators

Editor's Note The Food & Drug Administration (FDA) on February 15 identified Medtronic, Inc’s (Dublin, Ireland) recall of it’s Dual Chamber Implantable Pulse Generators (IPGs) as Class I, the most serious. The recall was initiated because of the possibility of a software error that can result in a lack of…

Read More

By: Judy Mathias
February 19, 2019
Share

FDA: Class I recall of Edwards Lifesciences Swan-Ganz Thermodilution Catheter

Editor's Note The Food and Drug Administration (FDA) on February 5 identified the recall by Edwards Lifesciences (Irvine, California) of its Swan-Ganz Thermodilution Catheter as Class I, the most serious. The recall was initiated because of incorrect assembly and reversal of catheter lumens that can expose the patient to serious…

Read More

By: Judy Mathias
February 14, 2019
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat